Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments (Evelyn Cheng/CNBC)
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
25/20
Brand Signal
6/15
Depth
3/15
5-Axis Cultural Radar
Evelyn Cheng / CNBC : Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments — BEIJING — U.S. pha
